TrialInternational journal of clinical oncology2022

Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.

Yoshihiko Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.